FDA approves Vanderbilt-designed Indego exoskeleton for clinical and personal use


Grantee News
March 15, 2016

The U.S. Food and Drug Administration (FDA) has given clearance to market and sell the powered lower-limb exoskeleton created by a team of Vanderbilt engineers and commercialized by the Parker Hannifin Corporation for both clinical and personal use in the United States. Read more at Vanderbilt University.